Welcome to our dedicated page for Regional Health news (Ticker: RHE), a resource for investors and traders seeking the latest updates and insights on Regional Health stock.
Regional Health (RHE) delivers specialized healthcare real estate solutions through strategic property management and facility optimization. This news hub provides investors and industry professionals with essential updates about the company's operational milestones and market positioning.
Access authoritative reports on earnings announcements, property acquisitions, and leadership developments. Our curated collection features press releases about medical facility transactions, governance updates, and financial disclosures that shape RHE's role in infrastructure management.
Discover timely insights into healthcare property investments and asset performance metrics. The resource serves as a centralized tracking point for strategic decisions impacting hospitals, clinics, and specialty care facilities nationwide.
Bookmark this page to monitor how Regional Health continues addressing healthcare infrastructure needs through disciplined capital allocation and operational expertise in medical real estate.
Regional Health Properties (RHE) has announced a dividend distribution of 250,000 shares of common stock to holders of its 12.5% Series B Cumulative Redeemable Preferred Shares. The distribution will be made on a pro rata basis, with shares rounded down to the nearest whole share. The dividend is scheduled for payment around February 19, 2025, with a record date of February 10, 2025.
The distribution is mandatory under Regional's Amended and Restated Articles of Incorporation. Shareholders will receive their shares in book entry form, with no physical certificates being issued. Notably, Series B Preferred Stock holders won't need to pay any cash, provide other consideration, or surrender their existing preferred shares to receive this distribution.
Regional Health Properties (RHE) and SunLink Health Systems (SSY) have announced a definitive merger agreement, creating a combined healthcare company. Under the terms, SunLink will merge with Regional in exchange for 1,410,000 shares of Regional common stock and 1,410,000 shares of newly-authorized Series D 8% Cumulative Convertible Redeemable Preferred Stock ($10 liquidation preference).
The deal will give SunLink shareholders approximately 43% ownership of the combined company. SunLink brings $17.6 million in total assets and no long-term debt. Regional expects pre-tax cost synergies of $1.0 million by fiscal 2026. The merged company will be led by Regional's CEO Brent Morrison, with SunLink's CEO Robert Thornton serving as Executive VP of Corporate Strategy. The board will expand to include industry veterans C. Christian Winkle and Scott Kellman.
The transaction, unanimously approved by both boards, is expected to close in spring 2025, subject to shareholder and regulatory approvals.
Regional Health Properties (NYSE American: RHE) announced its Q3 2024 financial results on November 26, 2024. The company reported a reduced loss from operations of $0.3 million, improved from $0.4 million in Q3 2023. Adjusted EBITDA increased to $1.0 million, compared to $0.6 million in the same period last year. The company collected 80.3% of contractual rent and remains optimistic about future collections.
Business highlights include the Healthcare Services segment achieving its first positive EBITDA since 2022 and the Meadowood facility in Glencoe, AL reaching its highest occupancy level since 2022. The overall portfolio CMS star rating is the highest in over two years.
Financially, the company reported total revenue of $4.2 million and a net loss of $1.0 million. As of September 30, 2024, Regional had $49.7 million net of outstanding debt, with a weighted-average interest rate of 5.1% and maturity of approximately 17 years. Post-quarter, a $0.5 million line of credit was obtained to ensure compliance with debt payments.
Regional Health Properties has received a delisting notice from NYSE American for both its common stock and Series A Preferred Shares. The NYSE Regulation determined the company failed to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide by the end of its 18-month compliance period on November 10, 2024.
The company has until November 18, 2024, to request a review by the Listings Qualifications Panel and intends to appeal the determination. Trading will continue during the appeal process. While the company is working to regain compliance, there is no guarantee of success.
FAQ
What is the current stock price of Regional Health (RHE)?
What is the market cap of Regional Health (RHE)?
